Peroxisome proliferator-activated receptor gamma modulation and lipogenic response in adipocytes of small-for-gestational age offspring

Nutrition and Metabolism

Volumn 9, Issue , 2012, Pages

  Yee, Jennifer K ^a   Lee, Wai Nang Paul ^a   Ross, Michael G ^a   Lane, Robert H ^b   Han, Guang ^a   Vega, Juan ^a   Desai, Mina ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

Adipocyte; Adipogenesis; Fatty acid; PPAR ; Rosiglitazone; Small for gestational age; Stable isotope

Indexed keywords

4,4' ISOPROPYLIDENEDIPHENOL; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROTEIN P21; ROSIGLITAZONE; STEROL REGULATORY ELEMENT BINDING PROTEIN 1;

ADIPOCYTE; ADIPOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; DIET RESTRICTION; FATTY ACID SYNTHESIS; FEMALE; GENE EXPRESSION; GLUCOSE UTILIZATION; MALE; MASS FRAGMENTOGRAPHY; NONHUMAN; PERINATAL PERIOD; PROGENY; PROTEIN EXPRESSION; RAT; SMALL FOR DATE INFANT;

ANIMALS; CELL DEATH; HIPPOCAMPUS; ION CHANNELS; MALE; MITOCHONDRIAL PROTEINS; NEURONS; PPAR GAMMA; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES; SEIZURES; SIGNAL TRANSDUCTION; STATUS EPILEPTICUS;

RATTUS;

EID: 84862546175     PISSN: None     EISSN: 17437075     Source Type: Journal    
DOI: 10.1186/1743-7075-9-62     Document Type: Article

References (31)

1. Obesity at the age of 50 y in men and women exposed to famine prenatally. Ravelli AC, van Der Meulen JH, Osmond C, Barker DJ, Bleker OP, Am J Clin Nutr 1999 70 811 816 (Pubitemid 29512905)
2. Obesity in young men after famine exposure in utero and early infancy. Ravelli GP, Stein ZA, Susser MW, N Engl J Med 1976 295 349 353
3. Organ-specific alterations in fatty acid de novo synthesis and desaturation in a rat model of programmed obesity. Yee JK, Lee WN, Han G, Ross MG, Desai M, Lipids Health Dis 2011 10 72
4. Programmed obesity in intrauterine growth-restricted newborns: modulation by newborn nutrition. Desai M, Gayle D, Babu J, Ross MG, Am J Physiol Regul Integr Comp Physiol 2005 288 91 R96
5. The timing of nutrient restriction during rat pregnancy/lactation alters metabolic syndrome phenotype. Desai M, Gayle D, Babu J, Ross MG, Am J Obstet Gynecol 2007 196 551 e557
6. Programmed hyperphagia due to reduced anorexigenic mechanisms in intrauterine growth-restricted offspring. Desai M, Gayle D, Han G, Ross MG, Reprod Sci 2007 14 329 337 (Pubitemid 351168813)
7. Programmed upregulation of adipogenic transcription factors in intrauterine growth-restricted offspring. Desai M, Guang H, Ferelli M, Kallichanda N, Lane RH, Reprod Sci 2008 15 785 796
8. ADD1/SREBP1 promotes adipocyte differentiation and gene expression linked to fatty acid metabolism. Kim JB, Spiegelman BM, Genes Dev 1996 10 1096 1107 (Pubitemid 26152851)
9. Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy. Kahn SE, Haffner SM, Heise MA, Herman WH, Holman RR, Jones NP, Kravitz BG, Lachin JM, O'Neill MC, Zinman B, Viberti G, N Engl J Med 2006 355 2427 2443 (Pubitemid 44903747)
10. Novel genes regulated by the insulin sensitizer rosiglitazone during adipocyte differentiation. Albrektsen T, Frederiksen KS, Holmes WE, Boel E, Taylor K, Fleckner J, Diabetes 2002 51 1042 1051 (Pubitemid 34438348)
11. Rosiglitazone increases the expression of peroxisome proliferator- activated receptor-gamma target genes in adipose tissue, liver, and skeletal muscle in the sheep fetus in late gestation. Muhlhausler BS, Morrison JL, McMillen IC, Endocrinology 2009 150 4287 4294
12. Effects of Rosiglitazone on the Expression of PPAR-gamma and the Production of IL-6 and IL-8 in Acute Lung Injury Model Using Human Pulmonary Epithelial Cells. Kim SK, Park CK, Lee SY, Song JS, Park SH, Kim YK, Trop J Pharm Res 2011 10 559 566
13. Prolonged decrease of adipocyte size after rosiglitazone treatment in high- and low-fat-fed rats. Johnson JA, Trasino SE, Ferrante AW, Vasselli JR, Obesity (Silver Spring) 2007 15 2653 2663
14. Direct demonstration of lipid sequestration as a mechanism by which rosiglitazone prevents fatty-acid-induced insulin resistance in the rat: comparison with metformin. Ye JM, Dzamko N, Cleasby ME, Hegarty BD, Furler SM, Cooney GJ, Kraegen EW, Diabetologia 2004 47 1306 1313 (Pubitemid 39093328)
15. Thiazolidinediones increase plasma-adipose tissue FFA exchange capacity and enhance insulin-mediated control of systemic FFA availability. Oakes ND, Thalen PG, Jacinto SM, Ljung B, Diabetes 2001 50 1158 1165 (Pubitemid 32374548)
16. A synthetic antagonist for the peroxisome proliferator-activated receptor gamma inhibits adipocyte differentiation. Wright HM, Clish CB, Mikami T, Hauser S, Yanagi K, Hiramatsu R, Serhan CN, Spiegelman BM, J Biol Chem 2000 275 1873 1877 (Pubitemid 30060811)
17. An overview on biological mechanisms of PPARs. Kota BP, Huang TH, Roufogalis BD, Pharmacol Res 2005 51 85 94 (Pubitemid 40040538)
18. Measurement of rates of lipogenesis with deuterated and tritiated water. Lowenstein JM, Brunengraber H, Wadke M, Methods Enzymol 1975 35 279 287
19. Mass isotopomer analysis: theoretical and practical considerations. Lee WN, Byerley LO, Bergner EA, Edmond J, Biol Mass Spectrom 1991 20 451 458
20. Compartmentalization of stearoyl-coenzyme A desaturase 1 activity in HepG2 cells. Yee JK, Mao CS, Hummel HS, Lim S, Sugano S, Rehan VK, Xiao G, Lee WN, J Lipid Res 2008 49 2124 2134
21. Mass isotopomer study of glutamine oxidation and synthesis in primary culture of astrocytes. Lee WN, Edmond J, Bassilian S, Morrow JW, Dev Neurosci 1996 18 469 477 (Pubitemid 26371590)
22. A critical perspective of the use of (13)C-isotopomer analysis by GCMS and NMR as applied to cardiac metabolism. Des Rosiers C, Lloyd S, Comte B, Chatham JC, Metab Eng 2004 6 44 58 (Pubitemid 38157795)
23. Glucose metabolism after traumatic brain injury: estimation of pyruvate carboxylase and pyruvate dehydrogenase flux by mass isotopomer analysis. Bartnik BL, Hovda DA, Lee PW, J Neurotrauma 2007 24 181 194 (Pubitemid 46214424)
24. Age, anatomic site, and the replication and differentiation of adipocyte precursors. Kirkland JL, Hollenberg CH, Gillon WS, Am J Physiol 1990 258 206 C210
25. Increased lipid accumulation in liver and white adipose tissue in aging in the SAMP10 mouse. Honma T, Yanaka M, Tsuduki T, Ikeda I, J Nutr Sci Vitaminol (Tokyo) 2011 57 123 129
26. Visceral adiposity without overweight in children born small for gestational age. Ibanez L, Lopez-Bermejo A, Suarez L, Marcos MV, Diaz M, de Zegher F, J Clin Endocrinol Metab 2008 93 2079 2083 (Pubitemid 351831518)
27. Thiazolidinediones. Yki-Jarvinen H, N Engl J Med 2004 351 1106 1118
28. De novo lipogenesis in the differentiating human adipocyte can provide all fatty acids necessary for maturation. Collins JM, Neville MJ, Pinnick KE, Hodson L, Ruyter B, van Dijk TH, Reijngoud DJ, Fielding MD, Frayn KN, J Lipid Res 2011 52 1683 1692
29. Living with the past: evolution, development, and patterns of disease. Gluckman PD, Hanson MA, Science 2004 305 1733 1736 (Pubitemid 39249632)
30. Thiazolidinedione treatment prevents free fatty acid-induced insulin resistance in male wistar rats. Hevener AL, Reichart D, Janez A, Olefsky J, Diabetes 2001 50 2316 2322 (Pubitemid 33641917)
31. Glutathione peroxidase 3 mediates the antioxidant effect of peroxisome proliferator-activated receptor gamma in human skeletal muscle cells. Chung SS, Kim M, Youn BS, Lee NS, Park JW, Lee IK, Lee YS, Kim JB, Cho YM, Lee HK, Park KS, Mol Cell Biol 2009 29 20 30